These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21563876)

  • 1. Tovaxin for multiple sclerosis.
    Rivera VM
    Expert Opin Biol Ther; 2011 Jul; 11(7):961-7. PubMed ID: 21563876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tovaxin, radiation-attenuated, patient-specific T-cells for the therapeutic vaccination of multiple sclerosis.
    Hellings N; Stinissen P
    Curr Opin Investig Drugs; 2008 May; 9(5):534-40. PubMed ID: 18465664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design.
    Fox E; Wynn D; Cohan S; Rill D; McGuire D; Markowitz C
    Mult Scler; 2012 Jun; 18(6):843-52. PubMed ID: 22065170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P; Raus J
    Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell vaccination as an immunotherapy for autoimmune diseases.
    Zhang J
    Cell Mol Immunol; 2004 Oct; 1(5):321-7. PubMed ID: 16285890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell vaccination in multiple sclerosis: hopes and facts.
    Zhang J; Raus J
    Acta Neurol Belg; 1994; 94(2):112-5. PubMed ID: 7518632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
    Hellings N; Raus J; Stinissen P
    Autoimmun Rev; 2004 Jun; 3(4):267-75. PubMed ID: 15246022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in treatment for multiple sclerosis].
    Kira J
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1261-3. PubMed ID: 11464473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation.
    Scholz C; Patton KT; Anderson DE; Freeman GJ; Hafler DA
    J Immunol; 1998 Feb; 160(3):1532-8. PubMed ID: 9570577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell vaccination in multiple sclerosis.
    Zhang I; Raus J
    Mult Scler; 1996 Jul; 1(6):353-6. PubMed ID: 9345417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
    de Rosbo NK; Ben-Nun A
    J Autoimmun; 1998 Aug; 11(4):287-99. PubMed ID: 9776706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis.
    Zang YC; Hong J; Tejada-Simon MV; Li S; Rivera VM; Killian JM; Zhang JZ
    Eur J Immunol; 2000 Mar; 30(3):908-13. PubMed ID: 10741408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell vaccination in multiple sclerosis: results of a preliminary study.
    Zhang JZ; Rivera VM; Tejada-Simon MV; Yang D; Hong J; Li S; Haykal H; Killian J; Zang YC
    J Neurol; 2002 Feb; 249(2):212-8. PubMed ID: 11985389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy.
    Zhang J
    Crit Rev Immunol; 2001; 21(1-3):41-55. PubMed ID: 11642613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal depletion of human myelin basic protein-reactive T-cells by T-cell vaccination.
    Zhang J; Raus J
    Ann N Y Acad Sci; 1995 Jul; 756():323-6. PubMed ID: 7544083
    [No Abstract]   [Full Text] [Related]  

  • 17. Myelin basic protein-reactive T cells in multiple sclerosis: pathologic relevance and therapeutic targeting.
    Zhang J; Raus J
    Cytotechnology; 1994; 16(3):181-7. PubMed ID: 7537052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations.
    Hermans G; Medaer R; Raus J; Stinissen P
    J Neuroimmunol; 2000 Jan; 102(1):79-84. PubMed ID: 10626670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.
    Zhang J; Medaer R; Stinissen P; Hafler D; Raus J
    Science; 1993 Sep; 261(5127):1451-4. PubMed ID: 7690157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies.
    Loftus B; Newsom B; Montgomery M; Von Gynz-Rekowski K; Riser M; Inman S; Garces P; Rill D; Zhang J; Williams JC
    Clin Immunol; 2009 May; 131(2):202-15. PubMed ID: 19230777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.